Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-05
2011-07-05
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S335000, C546S255000, C546S261000, C546S262000, C546S264000, C546S265000, C546S266000
Reexamination Certificate
active
07973059
ABSTRACT:
The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
REFERENCES:
patent: WO 2006/014877 (2006-02-01), None
patent: WO 2006/015159 (2006-02-01), None
Vippagunta et al., “Crystalline Solids”, Advanced Drug Delivery Reviews 48 (2001) 3-26.
Jain et al., “Polymorphism in Pharmacy”, Indian Drugs, 1986, 23(6), 315-329.
Guillory (in Brittain ed.), “Polymorphism, etc.,” NY: Marcel Dekker, Inc., 1999, 1-2, 183-226.
Burckhalter J. H. et al: “2-(2-Pyridyl-)-1, 2-diaryl alkonols as hypocholesteremi agents” Journal of Medicinal Chemistry, American Chemical Society, vol. 10, No. 4, 1967, pp. 565-575.
Villani F. J. et al: “Hypocholesteremic Agents. I. Substituted Stilbozoles and Dihydrostilbazoles”, Journal of Medicinal Chemistry, American Chemical Society, vol. 13, No. 3, 1970, pp. 359-366.
Bilodeau Mark T.
Nolt M. Brad
Wolkenberg Scott
Merck Sharp & Dohme Corp.
Morris Patricia L
Parr Richard S.
Struse Heidi M.
LandOfFree
Potassium channel inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potassium channel inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potassium channel inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699641